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There are some reports about combined effects of electromagnetic fields with known carcinogens, toxic physical or chemical agents.
In previous study, we observed that magnetic fields (60 Hz, 50 mT) enhance cytotoxicity of mitomycin C on E.coli bacterium. However,
it has not been clear about the effective condition of magnetic fields (magnetic flux density, frequency, exposure time etc.) on the potency
of chemical agents. In this study, we investigated the effective density and the action mechanisms of magnetic fields on the enhancement
of drugs potency. The result suggested that the enhancing effect of mitomycin C potency by exposure to magnetic fields depended on the
magnetic flux density. The potency of cisplatin, widely used in clinical cancer chemotherapy, was also enhanced by exposure to 60 Hz, 50
mT magnetic fields. The analysis of the potency of supernatant remaining drugs in the culture medium indicated that the intracellular
drug potency was increased and extracellular drug potency was decreased by exposure to magnetic fields. The values of drug potency
revealed a significant inverse correlation between intracellular and extracellular cells. These results suggested that magnetic fields (60
Hz, 50 mT) change the permeability of cell membrane and influence the drug intake.
Index Terms—Anticancer drug, enhancing effect, Extremely Low-Frequency (ELF) magnetic fields, membrane permeability.
I. INTRODUCTION
E XTREMELY LOW-FREQUENCY (ELF) magneticfields were classified as ‘2B; possibly carcinogenic to
humans’ by the International Agency for Research on Cancer
[1]. This classification was mainly based on limited human
epidemiological evidence for an association between ELF
magnetic fields exposure and childhood leukemia. No carcino-
genic effects of ELF magnetic fields have been found in animal
studies that have been tested. The differences on the evidence
from animal and human studies may be presumed that the
foods, drinks, and home environments and so on, life styles of
humans in epidemiological studies are various.
Then, there are some reports about combined effects of elec-
tromagnetic fields with known carcinogens, toxic physical or
chemical agents [2]–[6]. Tofani et al. reported that the survival
time of the C57BL/6 mouse bearing Lewis Lung carcinoma,
treated with cisplatin and exposed to ELF magnetic fields
was significantly longer than that of mice treated only with
cisplatin or only with magnetic fields. On the other hand, when
the mice bearing a B16 melanotic melanoma were exposed to
magnetic fields with anticancer drug, cyclophosphamide, the
survival curve was almost the same as that of mice treated with
cyclophosphamide alone, and no synergic effects of cyclophos-
phamide and magnetic fields were observed. These reports
suggested that the combination of magnetic fields and a certain
anticancer drug has a positive effect or at least no negative
effect in experimental cancer therapy.
In previous study, we observed that magnetic fields (60
Hz, 50 mT) enhance the potency of mitomycin C on Esh-
erichia.coli (E.coli) bacterium. Mitomycin C is genotoxic,
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antimicrobial agent, and used as anticancer drug in clinical
cancer chemotherapy.
If magnetic fields enable us to enhance the potency of anti-
cancer drug on target region only, the dosage can be reduced and
thus side effects can be suppressed. However, there are few de-
tailed data about the effective condition (magnetic flux density,
frequency and exposure time etc.) and the action mechanism,
of magnetic fields on the potency of chemical agents. In this
study, we investigated the effective density of magnetic fields
and the action mechanism on the enhancement of anticancer
drug potency.
II. MEASUREMENTS OF ANTICANCER DRUGS POTENCY BY
EXPOSURE TO ELF MAGNETIC FIELDS
A. Magnetic Fields Generator, Anticancer Drugs and Cells
The device used to generate ELF magnetic fields was com-
posed of laminated iron cores encircled by coils carrying cur-
rent. The magnetic fields (60 Hz) were generated in the experi-
mental area by exciting the coils and can reach a flux density of
50 mT with 1% uniformity. To avoid the influence of heat gen-
erated by the coil, the temperature change in the experimental
area was controlled by circulating water of 36 degree C (Fig. 1).
E. coliW3110 was from National BioResource Project E.coli
Strain of National Institute of Genetics Japan.
Mitomycin and cisplatin were purchased from Kyowa Hakko
Kirin Co., Ltd. and Maruko Pharmaceutical Co., Ltd.
A part of anticancer drugs used in clinical chemotherapy, such
as mitomycin C and cisplatin, act on DNA of all living organ-
isms as mutagen that can induce genetic mutation [7]. These
drugs such as mutagen act on all living organisms. In this study,
the potency of these drugs on bacterial cells under magnetic
fields was measured because our present system of ELF mag-
netic fields generator cannot supply the necessary CO for cul-
tivation of human cells.
B. Measurements of Anticancer Drugs Potency
The potency of drugs was measured from cell viability by
colony assay as follows.
0018-9464/$31.00 © 2012 IEEE
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Fig. 1. ELF magnetic fields generator.
Fig. 2. Protocol for measurement of the potency of intracellular and extracel-
lular drugs.
E.coli cells were grown in LB broth at 36 degree C [8]. E.coli
culture in logarithmic phase was added drug and divided into
two plastic tubes. One tube was placed in magnetic fields ex-
posure area (60 Hz, 5, 30 or 50 mT). Another one was placed
in non-exposure area. After reaction, cell culture was plated on
LB agar, solid medium. The agar media reduce cell movement
and allow cell to propagate into cell clones identified as single
colonies. The number of the colonies showed the number of vi-
able cells in sample, since single colony was formed from single
bacterial cell. If cell viability is decreased by exposure to mag-
netic fields, it means that the drug potency is enhanced by mag-
netic fields. On the other hand, if cell viability is increased, the
drug potency is inhibited.
To test whether magnetic fields change the membrane per-
meability of drugs or not, the potency of the drugs remaining
in the medium after exposure to magnetic fields was measured
as follows. After non-exposure or exposure to magnetic fields,
the E.coli culture including drugs was centrifuged (9 000 g 10
min), and the E.coli cells were precipitated and the supernatants
were included the remaining drug in the medium. The super-
natants were transferred into new cell culture and the potencies
of that were measured by colony assay (Fig. 2).
Fig. 3. Effect of 50 mT magnetic fields on the potency of mitomycin C. Cell
viability expressed as colony-forming unit/ml. Open symbols, without magnetic
fields; filled symbols, with 60 Hz, 50 mT magnetic fields. Mitomycin C (MMC)
concentrations are as follows, 0 g/ml ; 1 g/ml ; 2 g/ml ;
3 g/ml .
III. EFFECT OF ELF MAGNETIC FIELDS ON
MITOMYCIN C POTENCY
As shown in Fig. 3, the growth of E. coli cells exposed to
magnetic fields was the same as that of the non-exposed E. coli
cells. Therefore, 60 Hz, 50mTmagnetic fields have no influence
on the multiplication of E. coli cells.
The number of viable cells treated with mitomycin C at 1, 2
and 3 g/ml decreased from cfu/ml to
and cfu/ml, respectively, in 6 hours. By exposure to 60
Hz, 50 mTmagnetic fields, the cells treated with mitomycin C at
1, 2 and 3 g/ml for 6 hours resulted in decreasing to
and cfu/ml, respectively. This result sug-
gested that the viable cells were more decreased by the combi-
nation of mitomycin C and magnetic fields than that by MMC
only (open symbols to filled symbols in Fig. 3).
Since the potency of mitomycin C depends on the concentra-
tion, the relation between mitomycin C concentration and sur-
vival rate of the cells at reaction time 6 hours was shown in
Fig. 4 as open symbols. Then, the survival rates of the cells
treated with mitomycin C and magnetic fields were plotted as
filled symbols on the line of survival rate and mitomycin C con-
centrations. It was indicated that the cytocidal activity of mito-
mycin C at 1.0, 2.0, and 3.0 g/ml under 60 Hz, 50 mTmagnetic
fields has the same as that of 2.3, 4.9 and 6.9 g/ml of mito-
mycin C only, respectively (the concentration of filled symbols
in Fig. 4). This data suggests that the potency of mitomycin C at
each concentration was enhanced about 2.35-fold by exposure
to 50 mT magnetic fields for 6 hours. At 5 and 30 mT magnetic
fields for 6 hours reaction times, the enhancing rate of the mit-
omycin C potency was about 1.38 and 1.73-fold, respectively
(data not shown).
By contrast, the potency of mitomycin C was not changed
when mitomycin C was added in E.coli cell culture after ex-
posure to magnetic fields. And, the potency of mitomycin C
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Fig. 4. Relation between mitomycin C concentration and survival rate of the
cells at reaction time 6 hours. Open symbols, without magnetic fields; filled
symbols, with 60 Hz, 50 mT magnetic fields. Mitomycin C (MMC) concentra-
tions are as follows, 1 g/ml ; 2 g/ml ; 3 g/ml .
was not changed by exposure to magnetic fields of mitomycin
C molecules only (data not shown).
These results suggested that magnetic fields can potentiate
the cytotoxicity of mitomycin C and that the enhancing effect
of mitomycin C under magnetic fields depends on the magnetic
flux density.
IV. EFFECT OF ELF MAGNETIC FIELDS ON CELL MEMBRANE
PERMEABILITY OF ANTICANCER DRUGS
A part of mitomycin C added into the culture medium pene-
trates the cell membrane, acts on DNA and inhibits DNA repli-
cation. Then the extensive DNA damage leads to irreversible in-
jury and results in the cell death. In the above data (Figs. 3 and
4), colony assay measures the rate of the cell death. However,
there were the remaining drugs in the culture medium. There-
fore, the potency of the drugs remaining in the medium was
checked to see whether magnetic fields change the membrane
permeability of drugs or not.
In Fig. 5, the values of a vertical axis indicate the relative
ratio of the viable cells in the exposure group to the viable cells
in control group at each reaction time. When the value is 1.0,
it means that the number of viable cell of exposure group is
equal to that of control group at that reaction time. Fig. 5(a)
shows the comparison between the potency of mitomycin C (2
g/ml) under magnetic fields (60 Hz, 50 mT) and mitomycin
C (2 g/ml) only. By exposure to magnetic fields for 2 hours,
the viable cells were decreased to 0.57, that is, the enhancing
rate of mitomycin C potency was increased to 1.90-fold, relative
to non-exposure. On the other hand, Fig. 5(b) shows the com-
parison between the supernatant, remaining drugs in the culture
medium of mitomycin C (2 g/ml) under magnetic fields (60
Hz, 50 mT) and mitomycin C (2 g/ml) only. By exposure to
magnetic fields for 2 hours, the number of viable cells was in-
creased to 1.69-fold, that is, mitomycin C potency of the su-
pernatant was decreased to 0.62-fold, relative to non-exposure.
Fig. 5. (a) Comparison of the potency of magnetic field (MF, 60 Hz,
50 mT) MMC 2 g/ml and MMC 2 g/ml only. (b) Comparison of the
supernatant, remaining drugs in the medium of MF MMC 2 g/ml and MMC
2 g/ml only. Data are represented as the mean from 6 independent
experiments, to MMC only (non-MF Exposure).
TABLE I
EFFECTS OF 60 HZ, 50 MT MAGNETIC FIELDS ON CELL MEMBRANE
PERMEABILITY OF ANTICANCER DRUGS
As shown in Table I, intracellular mitomycin C potency was in-
creased to 1.90 and extracellular mitomycin C potency was de-
creased to 0.62 by exposure to 60 Hz, 50 mT magnetic fields.
These values revealed a significant inverse correlation between
intracellular and extracellular cells.
In addition, the result of cisplatin, widely used in clinical
cancer chemotherapy, was shown in Table I. By combination of
magnetic fields and cisplatin (70 g/ml) for 2 hours, the number
of viable cells was decreased to 0.75-fold, relative to non-ex-
posure, cisplatin (70 g/ml) only. The number of viable cells
by cisplatin potency of the supernatant under magnetic fields
was increased to 1.26-fold, that is, cisplatin potency of the su-
pernatant was decreased to 0.80-fold, relative to non-exposure.
Thus, the intracellular cisplatin potency was increased to 1.38
and extracellular ciaplatin potency was decreased to 0.80 by ex-
posure to 60 Hz, 50 mT magnetic fields. The result of cisplatin
shows that the values of drug potency revealed a significant in-
verse correlation between intracellular and extracellular cells,
as well as mitomycin C. These results suggested that ELF mag-
netic fields change the permeability of cell membrane and influ-
ence the drugs intake.
2872 IEEE TRANSACTIONS ON MAGNETICS, VOL. 48, NO. 11, NOVEMBER 2012
V. DISCUSSION
Several studies have reported that ELF magnetic fields have
induced changes in cell membranes [9]–[13]. Ikehara et al. ob-
served that 50 Hz magnetic fields (maximum of 41.7 to 43.6
mT) have effects on the peptide linkage and change the sec-
ondary structures of helix and sheet in membrane proteins of
living Hela cells by using attenuated total reflection infrared
spectroscopy [9]. After ELF magnetic exposure for 1 minute,
the exposure-caused changes in the secondary structure of pro-
tein were nearly recovered within 2 minutes, and the effect on
the protein structure was reversible.
Paradisi et al. indicated that 50 Hz magnetic fields (2.5 mT,
96 hours) induced significant changes in cell surface structure
and physiology by using means of scanning electron micro-
scope and electron paramagnetic resonance spectroscopy [10].
Without altering of cell proliferation, the cell surfaces non-cov-
ered by numerous short microvilli were observed by magnetic
fields exposure. Similarly, it was revealed that 50 Hz magnetic
fields change in plasmamembrane morphology and cytoskeletal
components in human lymphoblastoid cells Raji by observa-
tion of atomic force microscopy in air [10]. Santoro et al. ob-
served that 50 Hz magnetic fields (2 mT, 72 hours) decrease
in membrane fluidity as detected by Laurdan emission spec-
tromicroscopy and DPH fluorescence polarization. They also
showed 50 Hz magnetic fields can interfere with protein phos-
phorylation by the incorporation of in phosphoprotein and
protein electrophoresis analysis (SDS-PAGE) [12]. In addition,
Stange et al. shown that 50 Hz and 60 Hz magnetic fields in-
crease amino acid uptake into Vicia faba L. roots and alter ion
movement across the plasma membrane [13]. They suggested
that magnetic fields can cause alternation in the permeability of
the plasma membrane of plants root cells in vivo.
Those results are consistent with our present results and sug-
gested that ELF magnetic fields induce the change in the cell
membrane without effect on cell proliferation.
By the way, tumor cells have got the resistance properties
to many unrelated anticancer drugs identified as multidrug-
resistant during cancer chemotherapy. One mechanism of drug
resistance is thought to be due to the efflux of anticancer drugs
caused by P-glycoprotein in cell membrane. Liang et al. shows
that pulsed magnetic fields enhanced potency of anticancer
drug, daunorubicin against multidrug resistant human cell car-
cinoma subline [14]. They suggested that the pulsed magnetic
fields may inhibit the drug efflux-proteins on cell membrane
and then modulate daunorubicin potency.
Those reports indicated that exposure to magnetic fields may
be a helpful adjunct to chemotherapy. However, further studies
are needed to optimize the physical parameters of magnetic
fields, type of anticancer drugs and combination effects on
human cells.
VI. CONCLUSION
We investigated the effective density and the action mecha-
nisms, of magnetic fields on the enhancement of drugs potency.
The following three points were found in this study. (1) The po-
tencies of drugs such as mitomycin C and cisplatin on E.coli
cells were enhanced by exposure to 60 Hz magnetic fields. (2)
The enhancing effect of the potency of mitomycin C by mag-
netic fields depended on the magnetic flux density. (3) 60 Hz
magnetic fields seem to change the permeability of cell mem-
brane and influence the drug intake. Then, studies on the en-
hancing effect of anticancer drugs on human culture cells by
magnetic fields are now in progress.
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